The SNS (Strategic National Stockpile), which consists of pharmaceutical and non-pharmaceutical equipment, is meant to be deployed to state, local, tribal or territorial (SLTT) partners (pg 1). Deployment can occur in 12 hours or less for severe cases or when the required equipment is stationed nearby (such as CHEMPACKS for rapid antidote shipments). Other assets will be deployed up to 24 hours after it is decided to used them (pg 2).
Some pharmaceuticals in the SNS are in the Investigational New Drug phase, namely due to the lack of testing opportunities required to approve the drug (e.g anthrax vaccines for children under 18) (pg 3)
The SNS is capable of deploying refrigerated or frozen products, but SLTT partners are required to keep those products at the appropriate temperature upon arrival (pg 4).
SNS asset recipients are responsible for keeping track of the assets and the CDC’s shipping containers/equipment between receipt and dispensing (pg 4).
Ancillary equipment, such as ventilator parts, IV administration kits etc.., are not included to a complete extent in SNS assets so as to make room for other MCMs (pg 4). Overcoming this shortage may need to be an extra consideration for my thesis.
Bhavsar, Tina R., et al. “Planning Considerations for State, Local, Tribal, and Territorial Partners to Receive Medical Countermeasures From CDC’s Strategic National Stockpile During a Public Health Emergency.” American Journal of Public Health, vol. 108, no. S3, Sept. 2018, pp. S183–87. DOI.org (Crossref), doi:10.2105/AJPH.2018.304472.